Stock Analiz

Monopar Therapeutics (MNPR) stock forecast and price target

Price $72.00 · data as of November 13, 2026

12-month price target

Average target$130.17
Upside / downside+80.8%
Analysts12
ConsensusStrong buy
Low $119.00Average $130.17High $145.00

Gold marker: average target · white marker: today’s price ($72.00)

Analyst ratings

Strong buy 4Buy 8Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.86−54.4%$0
Next fiscal year
ends December 31, 2027
$-2.98−4.3%$27M
Next quarter
ends December 31, 2026
$-0.96−57.5%$0
Quarter after
ends March 31, 2027
$-1.31−184.2%$0

Consensus of the analysts covering Monopar Therapeutics, updated daily. In the last 30 days 4 estimates were raised and 4 lowered.

Frequently asked questions

What is the Monopar Therapeutics stock price target?

The average 12-month target from 12 analysts is $130.17, 80.8% above the current price of $72.00 Targets range from $119.00 to $145.00.

Is Monopar Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (4 strong buy, 8 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Monopar Therapeutics expected to earn?

Analysts expect EPS of $-2.86 for the fiscal year ending December 31, 2026 and $-2.98 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.